Skip to main content

Table 2 Peripheral levels of uric acid, albumin, and total bilirubin in schizophrenic patients in the acute stage and healthy controls

From: Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study

GroupUA (μmol/L)ALB (g/L)TBIL (μmol/L)
SCZ-AS(n = 107)308.29 ± 78.71a*42.79 ± 3.55a***18.43 ± 9.00a***
 Male(n = 40)350.45 ± 66.5444.02 ± 3.36a***19.74 ± 10.89 a***
 Female(n = 67)284.72 ± 75.45 a**42.05 ± 3.48 a***17.65 ± 7.65 a***
AU(n = 56)330.32 ± 81.69 a***,b**43.13 ± 3.17a***16.56 ± 5.37a***,b**
ANF(n = 51)286.19 ± 68.9442.40 ± 3.92 a***20.47 ± 11.49 a***
HC(n = 273)283.41 ± 68.6148.01 ± 3.2810.87 ± 5.18
 Male(n = 93)338.69 ± 52.4248.93 ± 4.2912.97 ± 6.24
 Female(n = 180)254.84 ± 57.7247.54 ± 2.499.78 ± 4.16
  1. *P < 0.05; **P < 0.01; ***P < 0.001
  2. a Compared with the healthy controls group. b Compared with the antipsychotics-naïve/free subgroup. SCZ-AS schizophrenic patients in the acute stage, AU antipsychotics-use, ANF antipsychotics-naïve/free, HC healthy control, UA uric acid, ALB albumin, TBIL total bilirubin